Health Effects of Grain Foods in Adults
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: High Whole Grain, Low Sugar, Low Whole Grain, Low Sugar, High Whole Grain, High Sugar, Low Whole Grain, High Sugar.
- Who it may be relevant to
- Registry conditions: High Whole Grain and Low Sugar, Medium Whole Grain and Low Sugar, Low Whole Grain and Low Sugar, Low Whole Grain and High Sugar. Basic parameters: 21 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study will assess the effects of eating whole grain foods versus refined grain foods with different amounts of added sugar. It is hypothesized that a diet including grain products will have beneficial effects on taste hedonics, appetite, food/energy intake, body weight, blood pressure, acute and chronic glycemia and acute and chronic lipemia compared to customary diets controlling for added sugars, saturated fats and sodium.
Detailed description
This 16-week, randomized, controlled, parallel-arm, clinical trial will assess the effects of consuming four different categories of grain foods on taste hedonics, appetite, food/energy intake, body weight, and blood pressure as well as acute and longer-term glycemia and lipemia. It will also examine the effects of foods varying in grain/carbohydrate composition on the microbiome and microbiota functionality. One hundred and twenty adults will be recruited and randomly assigned to one of four intervention groups. These groups will be defined by the diets they are prescribed. All will be prescribed diets containing approximately 50%; 35% and 15% energy from carbohydrate, fat and protein, respectively. Grain foods will comprise 50% of the carbohydrate component (i.e., 25% of total energy). The grain foods will be assigned to one of four categories based on whole grain content and concentrations of added sugars. The grain foods meeting these criteria will have the following composition:
Group 1 - High Whole Grain, Low Sugar 6 servings of whole grain and \<13% energy from added sugars.
Group 2 - Low Whole Grain, Low Sugar 3 servings of whole grain and \<13% energy from added sugars.
Group 3 - High Whole Grain, High Sugar 6 servings of whole grain and \>13% energy from added sugars.
Group 4 - Low Whole Grain, High Sugar 3 servings of whole grain and \>13% energy from added sugars.
Detailed Study Design
The study measures and timing are outlined in the following table:
Screening Week 1 Baseline Week 2 Week 5 Week 8 Week 11 Week 14 Fasting Blood X X X XX MTT X X X Weight X X X X X X Body Composition X X CGM X X X Intake X Hedonics (palatability) X X X Appetite X X X Activity X X X Blood Pressure X X X X X X Microbiota X X X X X Compliance X X X X X MTT = Meal Tolerance Test; DXA= Dual-energy X-ray Absorptiometry; CGM=Continuous glucose monitoring
Interventions
- Other High Whole Grain, Low Sugar
6 servings of whole grain and \<13% energy from added sugars. - Other Low Whole Grain, Low Sugar
3 servings of whole grain and \<13% energy from added sugars. - Other High Whole Grain, High Sugar
6 servings of whole grain and \>13% energy from added sugars. - Other Low Whole Grain, High Sugar
3 servings of whole grain and \>13% energy from added sugars.
Primary outcome measures
- Glycemia [Time frame: 12 weeks]
Secondary outcome measures (6)
- Appetite [Time frame: 12 weeks]
- Taste Hedonics [Time frame: 12 weeks]
- Energy Intake [Time frame: 12 weeks]
- Body Weight [Time frame: 12 weeks]
- Systolic and Diastolic Blood Pressure [Time frame: 12 weeks]
- Lipemia [Time frame: 12 weeks]
Eligibility criteria
Inclusion criteria
- male and female; 21 to 60 years old; Hemoglobin A1c concentration between 5.7 and 6.4%
- Prefer no use of medications, but if on medication, must have been on a stable dose for 3 months and plan to remain at the same dose for the duration of the trial.
- low customary intake of whole grain foods (less than 2 servings per day) and high energy from added sugar (greater than 10% energy).
Exclusion criteria
- Grain or dairy sensitivities or allergies or celiac disease; sensitivity or allergy to other foods that would result in refusal to eat a class of foods.
- smoker
- intended weight loss or gain during the study period; intended change of activity level during the study period
- use of blood thinners
- prior gastrointestinal surgery.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Basic science
Study locations
United States · 1 center
- Purdue University — West Lafayette
Identifiers
NCT: NCT06339879 · IRB-2023-1071